The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Contract Pharmaceutical Manufacturing Market Research Report 2024
Synopsis
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
The global Contract Pharmaceutical Manufacturing market was valued at US$ 87350 million in 2023 and is anticipated to reach US$ 131100 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.
Global Contract Pharmaceutical Manufacturing key players include Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, etc. Global top five players hold a share about 10%.
North America is the largest market, with a share about 30%, followed by Europe and China, having a total share about 30 percent.
In terms of product, API is the largest segment, with a share about 75%. And in terms of application, the largest application is Large Enterprise, followed by Small Medium Enterprise.
This report aims to provide a comprehensive presentation of the global market for Contract Pharmaceutical Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contract Pharmaceutical Manufacturing.
Report Scope
The Contract Pharmaceutical Manufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Contract Pharmaceutical Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Contract Pharmaceutical Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Catalent
DPx
Lonza
Piramal Healthcare
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie
Nipro Corp
Vetter
Sopharma
DPT Laboratories
Recipharm
NextPharma
Dishman
Aesica
Segment by Type
Oral
Injectable
API
Other
Segment by Application
Large Enterprise
Small Medium Enterprise
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Contract Pharmaceutical Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
The global Contract Pharmaceutical Manufacturing market was valued at US$ 87350 million in 2023 and is anticipated to reach US$ 131100 million by 2030, witnessing a CAGR of 5.9% during the forecast period 2024-2030.
Global Contract Pharmaceutical Manufacturing key players include Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, etc. Global top five players hold a share about 10%.
North America is the largest market, with a share about 30%, followed by Europe and China, having a total share about 30 percent.
In terms of product, API is the largest segment, with a share about 75%. And in terms of application, the largest application is Large Enterprise, followed by Small Medium Enterprise.
This report aims to provide a comprehensive presentation of the global market for Contract Pharmaceutical Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Contract Pharmaceutical Manufacturing.
Report Scope
The Contract Pharmaceutical Manufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Contract Pharmaceutical Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Contract Pharmaceutical Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Catalent
DPx
Lonza
Piramal Healthcare
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie
Nipro Corp
Vetter
Sopharma
DPT Laboratories
Recipharm
NextPharma
Dishman
Aesica
Segment by Type
Oral
Injectable
API
Other
Segment by Application
Large Enterprise
Small Medium Enterprise
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Contract Pharmaceutical Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Contract Pharmaceutical Manufacturing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Injectable
1.2.4 API
1.2.5 Other
1.3 Market by Application
1.3.1 Global Contract Pharmaceutical Manufacturing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Large Enterprise
1.3.3 Small Medium Enterprise
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Contract Pharmaceutical Manufacturing Market Perspective (2019-2030)
2.2 Contract Pharmaceutical Manufacturing Growth Trends by Region
2.2.1 Global Contract Pharmaceutical Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Contract Pharmaceutical Manufacturing Historic Market Size by Region (2019-2024)
2.2.3 Contract Pharmaceutical Manufacturing Forecasted Market Size by Region (2025-2030)
2.3 Contract Pharmaceutical Manufacturing Market Dynamics
2.3.1 Contract Pharmaceutical Manufacturing Industry Trends
2.3.2 Contract Pharmaceutical Manufacturing Market Drivers
2.3.3 Contract Pharmaceutical Manufacturing Market Challenges
2.3.4 Contract Pharmaceutical Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Contract Pharmaceutical Manufacturing Players by Revenue
3.1.1 Global Top Contract Pharmaceutical Manufacturing Players by Revenue (2019-2024)
3.1.2 Global Contract Pharmaceutical Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Contract Pharmaceutical Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Contract Pharmaceutical Manufacturing Revenue
3.4 Global Contract Pharmaceutical Manufacturing Market Concentration Ratio
3.4.1 Global Contract Pharmaceutical Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Contract Pharmaceutical Manufacturing Revenue in 2023
3.5 Contract Pharmaceutical Manufacturing Key Players Head office and Area Served
3.6 Key Players Contract Pharmaceutical Manufacturing Product Solution and Service
3.7 Date of Enter into Contract Pharmaceutical Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Contract Pharmaceutical Manufacturing Breakdown Data by Type
4.1 Global Contract Pharmaceutical Manufacturing Historic Market Size by Type (2019-2024)
4.2 Global Contract Pharmaceutical Manufacturing Forecasted Market Size by Type (2025-2030)
5 Contract Pharmaceutical Manufacturing Breakdown Data by Application
5.1 Global Contract Pharmaceutical Manufacturing Historic Market Size by Application (2019-2024)
5.2 Global Contract Pharmaceutical Manufacturing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Contract Pharmaceutical Manufacturing Market Size (2019-2030)
6.2 North America Contract Pharmaceutical Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Contract Pharmaceutical Manufacturing Market Size by Country (2019-2024)
6.4 North America Contract Pharmaceutical Manufacturing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Contract Pharmaceutical Manufacturing Market Size (2019-2030)
7.2 Europe Contract Pharmaceutical Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Contract Pharmaceutical Manufacturing Market Size by Country (2019-2024)
7.4 Europe Contract Pharmaceutical Manufacturing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Contract Pharmaceutical Manufacturing Market Size (2019-2030)
8.2 Asia-Pacific Contract Pharmaceutical Manufacturing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Contract Pharmaceutical Manufacturing Market Size by Region (2019-2024)
8.4 Asia-Pacific Contract Pharmaceutical Manufacturing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Contract Pharmaceutical Manufacturing Market Size (2019-2030)
9.2 Latin America Contract Pharmaceutical Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Contract Pharmaceutical Manufacturing Market Size by Country (2019-2024)
9.4 Latin America Contract Pharmaceutical Manufacturing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Contract Pharmaceutical Manufacturing Market Size (2019-2030)
10.2 Middle East & Africa Contract Pharmaceutical Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Country (2019-2024)
10.4 Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Detail
11.1.2 Catalent Business Overview
11.1.3 Catalent Contract Pharmaceutical Manufacturing Introduction
11.1.4 Catalent Revenue in Contract Pharmaceutical Manufacturing Business (2019-2024)
11.1.5 Catalent Recent Development
11.2 DPx
11.2.1 DPx Company Detail
11.2.2 DPx Business Overview
11.2.3 DPx Contract Pharmaceutical Manufacturing Introduction
11.2.4 DPx Revenue in Contract Pharmaceutical Manufacturing Business (2019-2024)
11.2.5 DPx Recent Development
11.3 Lonza
11.3.1 Lonza Company Detail
11.3.2 Lonza Business Overview
11.3.3 Lonza Contract Pharmaceutical Manufacturing Introduction
11.3.4 Lonza Revenue in Contract Pharmaceutical Manufacturing Business (2019-2024)
11.3.5 Lonza Recent Development
11.4 Piramal Healthcare
11.4.1 Piramal Healthcare Company Detail
11.4.2 Piramal Healthcare Business Overview
11.4.3 Piramal Healthcare Contract Pharmaceutical Manufacturing Introduction
11.4.4 Piramal Healthcare Revenue in Contract Pharmaceutical Manufacturing Business (2019-2024)
11.4.5 Piramal Healthcare Recent Development
11.5 Aenova
11.5.1 Aenova Company Detail
11.5.2 Aenova Business Overview
11.5.3 Aenova Contract Pharmaceutical Manufacturing Introduction
11.5.4 Aenova Revenue in Contract Pharmaceutical Manufacturing Business (2019-2024)
11.5.5 Aenova Recent Development
11.6 Jubilant
11.6.1 Jubilant Company Detail
11.6.2 Jubilant Business Overview
11.6.3 Jubilant Contract Pharmaceutical Manufacturing Introduction
11.6.4 Jubilant Revenue in Contract Pharmaceutical Manufacturing Business (2019-2024)
11.6.5 Jubilant Recent Development
11.7 Famar
11.7.1 Famar Company Detail
11.7.2 Famar Business Overview
11.7.3 Famar Contract Pharmaceutical Manufacturing Introduction
11.7.4 Famar Revenue in Contract Pharmaceutical Manufacturing Business (2019-2024)
11.7.5 Famar Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Detail
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Introduction
11.8.4 Boehringer Ingelheim Revenue in Contract Pharmaceutical Manufacturing Business (2019-2024)
11.8.5 Boehringer Ingelheim Recent Development
11.9 Fareva Holding
11.9.1 Fareva Holding Company Detail
11.9.2 Fareva Holding Business Overview
11.9.3 Fareva Holding Contract Pharmaceutical Manufacturing Introduction
11.9.4 Fareva Holding Revenue in Contract Pharmaceutical Manufacturing Business (2019-2024)
11.9.5 Fareva Holding Recent Development
11.10 AbbVie
11.10.1 AbbVie Company Detail
11.10.2 AbbVie Business Overview
11.10.3 AbbVie Contract Pharmaceutical Manufacturing Introduction
11.10.4 AbbVie Revenue in Contract Pharmaceutical Manufacturing Business (2019-2024)
11.10.5 AbbVie Recent Development
11.11 Nipro Corp
11.11.1 Nipro Corp Company Detail
11.11.2 Nipro Corp Business Overview
11.11.3 Nipro Corp Contract Pharmaceutical Manufacturing Introduction
11.11.4 Nipro Corp Revenue in Contract Pharmaceutical Manufacturing Business (2019-2024)
11.11.5 Nipro Corp Recent Development
11.12 Vetter
11.12.1 Vetter Company Detail
11.12.2 Vetter Business Overview
11.12.3 Vetter Contract Pharmaceutical Manufacturing Introduction
11.12.4 Vetter Revenue in Contract Pharmaceutical Manufacturing Business (2019-2024)
11.12.5 Vetter Recent Development
11.13 Sopharma
11.13.1 Sopharma Company Detail
11.13.2 Sopharma Business Overview
11.13.3 Sopharma Contract Pharmaceutical Manufacturing Introduction
11.13.4 Sopharma Revenue in Contract Pharmaceutical Manufacturing Business (2019-2024)
11.13.5 Sopharma Recent Development
11.14 DPT Laboratories
11.14.1 DPT Laboratories Company Detail
11.14.2 DPT Laboratories Business Overview
11.14.3 DPT Laboratories Contract Pharmaceutical Manufacturing Introduction
11.14.4 DPT Laboratories Revenue in Contract Pharmaceutical Manufacturing Business (2019-2024)
11.14.5 DPT Laboratories Recent Development
11.15 Recipharm
11.15.1 Recipharm Company Detail
11.15.2 Recipharm Business Overview
11.15.3 Recipharm Contract Pharmaceutical Manufacturing Introduction
11.15.4 Recipharm Revenue in Contract Pharmaceutical Manufacturing Business (2019-2024)
11.15.5 Recipharm Recent Development
11.16 NextPharma
11.16.1 NextPharma Company Detail
11.16.2 NextPharma Business Overview
11.16.3 NextPharma Contract Pharmaceutical Manufacturing Introduction
11.16.4 NextPharma Revenue in Contract Pharmaceutical Manufacturing Business (2019-2024)
11.16.5 NextPharma Recent Development
11.17 Dishman
11.17.1 Dishman Company Detail
11.17.2 Dishman Business Overview
11.17.3 Dishman Contract Pharmaceutical Manufacturing Introduction
11.17.4 Dishman Revenue in Contract Pharmaceutical Manufacturing Business (2019-2024)
11.17.5 Dishman Recent Development
11.18 Aesica
11.18.1 Aesica Company Detail
11.18.2 Aesica Business Overview
11.18.3 Aesica Contract Pharmaceutical Manufacturing Introduction
11.18.4 Aesica Revenue in Contract Pharmaceutical Manufacturing Business (2019-2024)
11.18.5 Aesica Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
